Level A· Stronger Clinical EvidenceSystematic ReviewEurope PMCOpen access

Regenerative potential of Dental Pulp Stem Cells (DPSCs) in dental and periodontal tissue engineering: a systematic review of preclinical and clinical studies

Asghari S., Rezaee S., Khaneshi N., Rostami M., Batebi M., Heidari F.

Systematic Review on Ligament Injury, Immune Modulation, published in BMC Oral Health (2026) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Systematic Review
Journal
BMC Oral Health (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42151984
PMCID
PMC13235031
DOI
10.1186/s12903-026-08420-5

Abstract (original English)

Dental pulp stem cells (DPSCs) are multipotent mesenchymal stem cells with demonstrated potential for regenerating dental and periodontal tissues. This systematic review aimed to critically evaluate the regenerative potential, biological properties, and translational prospects of DPSCs in dental and periodontal tissue engineering, based on in vitro, in vivo, and clinical interventional studies published between 2010 and 2025. A comprehensive literature search was conducted in PubMed, Web of Science, Embase, and Scopus using combinations of keywords related to DPSCs, dental/periodontal regeneration, and tissue engineering. Quality assessment was performed using the Downs and Black checklist, and the risk of bias was also evaluated with RoB 2 and ROBINS-I tools. A total of 12 interventional studies (9 experimental and 3 clinical trials) were included. DPSCs consistently indicated high proliferation, multilineage differentiation, immunomodulatory capacity, and resistance to inflammatory and senescence-inducing conditions compared to other mesenchymal stem cell sources. Preclinical studies demonstrated the enhanced regeneration of dental pulp, dentin, periodontal ligament, cementum, and alveolar bone using DPSCs, with or without scaffolds and bioactive cues. Clinical trials reported the safety of autologous DPSCs and improvements in pulp vitality, probing depth, clinical attachment

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
Stem CellsMesenchymal Stem CellsPeriodontiumDental PulpAnimalsHumansStem Cell TransplantationTissue EngineeringRegeneration

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research